Evidence map›Paper›PMID 40214457›Full record

ArticleCells2025

Cigarette Smoke Exposure Leads to Organic and Mineral Bone Component Changes: The Importance of Rho Kinase Function in These Events.

Alex Ferreira da Silva, Franciele Jesus Lima, Alyne Riani Moreira, Cintia do Nascimento Silva, Ivone Braga de Oliveira, Alexandra Fernandes Callera, Ana Luiza Porfirio, Luan Henrique Vasconcelos Alves, Iolanda de Fátima Lopes Calvo Tibério, Ana Paula Pereira Velosa and 3 more

Abstract read
In one paragraph

Article in Cells, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Maternal Exposure to Wood-Smoke-Derived PMInternational journal of molecular sciences · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Alex Ferreira da SilvaLaboratory of Experimental Therapeutics (LIM-20), Department of Medicine, School of Medicine, University of São Paulo, São Paulo 01246-903, Brazil.ORCID 0009-0001-6422-9483
Franciele Jesus LimaLaboratory of Experimental Therapeutics (LIM-20), Department of Medicine, School of Medicine, University of São Paulo, São Paulo 01246-903, Brazil.
Alyne Riani MoreiraLaboratory of Experimental Therapeutics (LIM-20), Department of Medicine, School of Medicine, University of São Paulo, São Paulo 01246-903, Brazil.
Cintia do Nascimento SilvaLaboratory of Experimental Therapeutics (LIM-20), Department of Medicine, School of Medicine, University of São Paulo, São Paulo 01246-903, Brazil.
Ivone Braga de OliveiraLaboratory of Renal Physiopathology (LIM-16), Department of Medicine, School of Medicine, University of São Paulo, São Paulo 01246-903, Brazil.
Alexandra Fernandes CalleraLaboratory of Experimental Therapeutics (LIM-20), Department of Medicine, School of Medicine, University of São Paulo, São Paulo 01246-903, Brazil.ORCID 0009-0009-9278-2743
Ana Luiza PorfirioLaboratory of Experimental Therapeutics (LIM-20), Department of Medicine, School of Medicine, University of São Paulo, São Paulo 01246-903, Brazil.
Luan Henrique Vasconcelos AlvesLaboratory of Experimental Therapeutics (LIM-20), Department of Medicine, School of Medicine, University of São Paulo, São Paulo 01246-903, Brazil.ORCID 0000-0001-5371-6967
Iolanda de Fátima Lopes Calvo TibérioLaboratory of Experimental Therapeutics (LIM-20), Department of Medicine, School of Medicine, University of São Paulo, São Paulo 01246-903, Brazil.ORCID 0000-0002-5662-7895
Ana Paula Pereira VelosaRheumatology Division (LIM-17), School of Medicine, University of São Paulo, São Paulo 01246-903, Brazil.
Vanda JorgettiLaboratory of Renal Physiopathology (LIM-16), Department of Medicine, School of Medicine, University of São Paulo, São Paulo 01246-903, Brazil.
Walcy Rosolia TeodoroRheumatology Division (LIM-17), School of Medicine, University of São Paulo, São Paulo 01246-903, Brazil.
Fernanda Degobbi Tibério Quirino Dos Santos LopesLaboratory of Experimental Therapeutics (LIM-20), Department of Medicine, School of Medicine, University of São Paulo, São Paulo 01246-903, Brazil.ORCID 0000-0002-6402-3055

Funding

Fundação de Amparo à Pesquisa do Estado de São Paulo 2022/07357-0National Council for Scientific and Technological Development 302957/2021-9
6 · The paper itself

Abstract

Aberrant Rho-associated kinase function could be associated with increased bone fragility. Since cigarette smoke (CS) exposure promotes the increase in bone fragility due to changes in bone tissue components, this study aimed to investigate how CS exposure could modulate the Rho kinase-associated bone structural changes. Mice were assigned to four groups: control; smoke; control with Rho kinase inhibitor administration; and smoke with a Rho kinase inhibitor. Bone samples were obtained to assess bone histomorphometry analysis, type I collagen composition, and MEPE expression in trabeculae. We observed that CS exposure induced decreased trabecular and osteoid thickness. A concomitant increase in the osteoclastic and erosion surfaces and a decrease in the mineralization surface were observed. Additionally, CS exposure decreased the type I collagen and MEPE expression. Rho kinase inhibitor administration recovered the bone mineralization and the collagen type I deposition. Conclusions: CS exposure increases Rho kinase activity in bone cells, leading to structural changes. The administration of a Rho GTPases inhibitor partially reverses these effects, likely due to the recovery in osteoblast activity.

Indexed as

Bone and Bonesrho-Associated KinasesSmokeAnimalsCalcification, PhysiologicCollagen Type IMaleMiceMice, Inbred C57BLOsteoblastsOsteoclastsCollagen Type Irho-Associated KinasesSmokemineral componentsosteoblast activityRho kinase inhibitorsmoking

Identifiers

PMID40214457
PMCPMC11987806

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.